In contrast, the knockdown of OTUD5 resulted in the loss of activity of PDCD5 and p53 proteins, promoting proliferation, metastasis, drug resistance, and apoptosis resistance in NSCLC cells [74]. The gene discussed is PDCD5; the disease is non-small cell lung carcinoma.